Brought to you by 
Teva acquires Pfizer's Dorom SRL for €70mm in cash
18 Aug 2004
Executive Summary
Teva Pharmaceutical Industries (generics) has agreed to buy Dorom SRL, an Italian generic drug company owned by Pfizer. The cash transaction values Dorom at 2.3 times its sales for the 12 months ending June 2004, or about €70mm ($85mm).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Teva acquires Pfizer's Dorom SRL for €70mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice